Literature DB >> 28971748

Immuno-oncology in urothelial carcinoma: who or what will ultimately sit on the iron throne?

Jorge D Ramos1,2, Evan Y Yu1,2.   

Abstract

Entities:  

Keywords:  IDO1; adoptive T-cell therapy; bladder cancer; checkpoint inhibitors; immuno-oncology

Mesh：

Substances：

Year:  2017        PMID： 28971748     DOI： 10.2217/imt-2017-0109

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  2 in total

Review 1.  Cell Therapies in Bladder Cancer Management.

Authors:  Lucia Morales; Jesús M Paramio
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

2.  Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.

Authors:  Risa L Wong; Lorin A Ferris; Olivia A Do; Sarah K Holt; Jorge D Ramos; Simon J Crabb; Cora N Sternberg; Joaquim Bellmunt; Sylvain Ladoire; Ugo De Giorgi; Lauren C Harshman; Ulka N Vaishampayan; Andrea Necchi; Sandy Srinivas; Sumanta K Pal; Guenter Niegisch; Tanya B Dorff; Matthew D Galsky; Evan Y Yu
Journal:  Oncologist       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.